Citadel Advisors’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Citadel Advisors’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,590	Closed	-$1.62K	–	15370
2023 Q2	$1.62K	Buy	+11,590	New	+$950	﹤0.01%	13897
2023 Q1	–	Sell	-12,825	Closed	-$823	–	15756
2022 Q4	$823	Buy	+12,825	New	+$1.05K	﹤0.01%	14576
2022 Q2	–	Sell	-256,890	Closed	-$102K	–	14425
2022 Q1	$102K	Sell	256,890 -187,500	-42%	-$85.3K	﹤0.01%	12267
2021 Q4	$293K	Buy	444,390 +187,500	+73%	+$126K	﹤0.01%	10983
2021 Q3	$177K	Hold	256,890	–	–	﹤0.01%	12156
2021 Q2	$239K	Buy	+256,890	New	+$205K	﹤0.01%	11787

Other funds holding AONCW

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Citadel Advisors's AONCW Position: Q3 2023 in Review

Citadel Advisors sold out of American Oncology Network, Inc. Warrant (AONCW) in Q3 2023, closing a stake of 11,590 shares — an estimated $1.62K sold.

Citadel Advisors first reported a position in AONCW in Q2 2021 and held it in 6 quarters. The position peaked at $293K in Q4 2021. 34 funds tracked by Wall St. Rank hold AONCW as of Q3 2023.

Citadel Advisors reported no remaining American Oncology Network, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 11,590 American Oncology Network, Inc. Warrant shares in Q3 2023, an estimated $1.62K.
Citadel Advisors first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 6 quarters.
Citadel Advisors's American Oncology Network, Inc. Warrant position peaked at $293K in Q4 2021.
34 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.